152 related articles for article (PubMed ID: 15864127)
1. Beta2-adrenoceptor gene polymorphisms.
Brodde OE; Leineweber K
Pharmacogenet Genomics; 2005 May; 15(5):267-75. PubMed ID: 15864127
[TBL] [Abstract][Full Text] [Related]
2. Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes.
Leineweber K; Brodde OE
Life Sci; 2004 Apr; 74(23):2803-14. PubMed ID: 15072081
[TBL] [Abstract][Full Text] [Related]
3. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases.
Brodde OE
Fundam Clin Pharmacol; 2008 Apr; 22(2):107-25. PubMed ID: 18353108
[TBL] [Abstract][Full Text] [Related]
4. Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo.
Bruck H; Leineweber K; Park J; Weber M; Heusch G; Philipp T; Brodde OE
Clin Pharmacol Ther; 2005 Sep; 78(3):232-8. PubMed ID: 16153394
[TBL] [Abstract][Full Text] [Related]
5. Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.
Leineweber K; Heusch G
Br J Pharmacol; 2009 Sep; 158(1):61-9. PubMed ID: 19422376
[TBL] [Abstract][Full Text] [Related]
6. Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics*.
Kukreti R; Bhatnagar P; B-Rao C; Gupta S; Madan B; Das C; Guleria R; Athavale AU; Brahmachari SK; Ghosh B
Pharmacogenomics; 2005 Jun; 6(4):399-410. PubMed ID: 16004558
[TBL] [Abstract][Full Text] [Related]
7. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
[TBL] [Abstract][Full Text] [Related]
8. Limited beta2-adrenoceptor haplotypes display different agonist mediated airway responses in asthmatics.
van Veen A; Wierenga EA; Westland R; Weller FR; Hart GA; Jansen HM; Jonkers RE
Respir Res; 2006 Jan; 7(1):19. PubMed ID: 16448568
[TBL] [Abstract][Full Text] [Related]
9. Association of beta2 adrenergic receptor polymorphisms and related haplotypes with triglyceride and LDL-cholesterol levels.
Petrone A; Zavarella S; Iacobellis G; Zampetti S; Vania A; Di Pietro S; Galgani A; Leonetti F; Di Mario U; Buzzetti R
Eur J Hum Genet; 2006 Jan; 14(1):94-100. PubMed ID: 16251889
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome.
Kanki H; Yang P; Xie HG; Kim RB; George AL; Roden DM
J Cardiovasc Electrophysiol; 2002 Mar; 13(3):252-6. PubMed ID: 11942593
[TBL] [Abstract][Full Text] [Related]
11. [Interactions between beta1 and beta2 adrenergic receptor polymorphisms as risk factors for chronic heart failure].
Moraga F; Troncoso R; Mellado R; Díaz-Araya G; Vukasovic JL; Greig D; Perez O; García L; Roldán J; Ocaranza MP; Jali J; Chiong M; Castro P
Rev Med Chil; 2008 Nov; 136(11):1371-80. PubMed ID: 19301767
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenoceptor polymorphisms.
Leineweber K; Büscher R; Bruck H; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):1-22. PubMed ID: 14647973
[TBL] [Abstract][Full Text] [Related]
13. Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy.
Badenhorst D; Norton GR; Sliwa K; Brooksbank R; Essop R; Sareli P; Woodiwiss AJ
Pharmacogenomics J; 2007 Oct; 7(5):339-45. PubMed ID: 17117186
[TBL] [Abstract][Full Text] [Related]
14. Association of haplotypes of beta2-adrenoceptor polymorphisms with lung function and airway responsiveness in a pediatric cohort.
Zhang G; Hayden CM; Khoo SK; Laing IA; Turner S; Landau L; Goldblatt J; Le Souëf PN
Pediatr Pulmonol; 2006 Dec; 41(12):1233-41. PubMed ID: 17068824
[TBL] [Abstract][Full Text] [Related]
15. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
[TBL] [Abstract][Full Text] [Related]
16. Beta-adrenergic receptor polymorphism in human cardiovascular disease.
Leineweber K
Ann Med; 2004; 36 Suppl 1():64-9. PubMed ID: 15176426
[TBL] [Abstract][Full Text] [Related]
17. Beta2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells.
Lipworth B; Koppelman GH; Wheatley AP; Le Jeune I; Coutie W; Meurs H; Kauffman HF; Postma DS; Hall IP
Thorax; 2002 Jan; 57(1):61-6. PubMed ID: 11809992
[TBL] [Abstract][Full Text] [Related]
18. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
[TBL] [Abstract][Full Text] [Related]
19. Beta-2 adrenergic receptor gene polymorphisms Gln27Glu, Arg16Gly in patients with heart failure.
Mansur AJ; Fontes RS; Canzi RA; Nishimura R; Alencar AP; de Lima AC; Krieger JE; Pereira AC
BMC Cardiovasc Disord; 2009 Nov; 9():50. PubMed ID: 19886995
[TBL] [Abstract][Full Text] [Related]
20. Beta1 and beta2-adrenergic receptor polymorphisms and idiopathic ventricular arrhythmias.
Ulucan C; Cetintas V; Tetik A; Eroglu Z; Kayikcioglu M; Can LH; Payzin S; Aydin M; Hasdemir C
J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1053-8. PubMed ID: 18479335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
